Homocysteine and migraine

July 24, 2009

High homocysteine levels increase the risk of cardiovascular disease (strokes and heart attacks) and can be reduced by folic acid and vitamin B12 (cyanocobalamine). A study by Spanish doctors published in Headache found elevated homocysteine levels in patients who have migraines with aura. Patients who have migraine with aura are known to have increased risk of cardiovascular disease and it is possible that elevated homocysteine levels are at least in part responsible for this risk. I routinely check homocysteine, vitamin B12 and folic acid levels in all of my patients. One caveat is that vitamin B12 levels are not very reliable – you may have a normal level, but still be deficient. While laboratories consider a level of over 200 to be normal, clinical deficiency is often present at levels below 400. A single case report has been published of a severe deficiency with neurological symptoms and a vitamin B12 level of over 700. This patient lacked the ability to transport vitamin B12 from his blood into the cells. Injections of high doses of vitamin B12 corrected the problem. Oral magnesium supplementation is not as effective as injections because vitamin B12 is poorly absorbed in the stomach. Other ways to get vitamin B12 is by taking it sublingually (under your tongue) or by a nasal spray (it requires a prescription and is fairly expensive). Many of my patients a willing to self-inject vitamin B12, which they do anywhere fro once a week to once a month. Vegetarians are more likely to be deficient since meat (and liver) are the main sources of vitamin B12. Smokers are also at a high risk because cyanide in smoke binds to vitamin B12.

Written by
Alexander Mauskop, MD
Continue reading
May 21, 2026
Research
Your Brain Has Many Pathways, And TMS Can Now Use Them
A groundbreaking University of Iowa study shows that personalized fMRI-guided TMS can now reach and modulate the deep hippocampus — the brain’s command center for memory, emotion, and migraine — without surgery or heavy medications. By mapping each patient’s unique neural pathways, TMS delivers precise stimulation to surface “control points” that influence deep brain structures. Generic approaches barely work, but individualized targeting produces clear, measurable changes. At our headache clinic, we combine TMS and fMRI to offer this advanced, personalized treatment for migraines, depression, PTSD, anxiety, and more.
Read article
May 10, 2026
Research
Elismetrep: A Promising New Experimental Migraine Treatment
Elismetrep is a promising experimental migraine medication that targets the TRPM8 pathway rather than serotonin or CGRP. Early clinical trials suggest it may offer a new option for patients who do not respond well to current treatments.
Read article
May 6, 2026
Alternative Therapies
New Research on Brain Excitability and TMS Treatment for Migraine
New research shows how the brain dynamically regulates excitability in real time—and why this matters for transcranial magnetic stimulation (TMS) as a treatment for migraine.
Read article
Insights from Dr. Alexander Mauskop on headaches and migraines
Subscribe to the Blog.
Subscribe
Subscribe